Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-11 1:04 pm Purchase | 2025-08-11 | 13G | Galecto, Inc. GLTO | Otto Erik | 1,690,000 8.100% | 1,690,000![]() (New Position) | Filing History |
| 2025-08-07 4:21 pm Sale | 2025-07-31 | 13G | Chemomab Therapeutics Ltd. CMMB | MORGAN STANLEY MS | 3,303,315 3.200% | -4,767,355![]() (-59.07%) | Filing History |
| 2025-08-07 11:45 am Purchase | 2025-06-30 | 13G | Chemomab Therapeutics Ltd. CMMB | MORGAN STANLEY MS | 8,070,670 8.400% | 8,070,670![]() (New Position) | Filing History |
| 2025-06-23 5:06 pm Sale | 2025-06-18 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 242,452 4.800% | -222,775![]() (-47.89%) | Filing History |
| 2025-04-10 5:25 pm Sale | 2025-03-31 | 13G | Chemomab Therapeutics Ltd. CMMB | SPHERA FUNDS MANAGEMENT LTD. | 225,107 4.780% | -78,537![]() (-25.86%) | Filing History |
| 2024-11-29 3:04 pm Purchase | 2024-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 224,555 4.800% | 37,694![]() (+20.17%) | Filing History |
| 2024-11-21 10:59 am Purchase | 2024-11-21 | 13G | Chemomab Therapeutics Ltd. CMMB | Otto Erik | 288,750 6.100% | 288,750![]() (New Position) | Filing History |
| 2024-09-16 4:34 pm Sale | 2024-09-12 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 465,227 9.990% | -102,296![]() (-18.03%) | Filing History |
| 2024-08-20 2:36 pm Purchase | 2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB | SPHERA FUNDS MANAGEMENT LTD. | 303,644 6.560% | 303,644![]() (New Position) | Filing History |
| 2024-03-11 7:19 pm Unchanged | 2024-03-11 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 16.000% | 0 (Unchanged) | Filing History |
| 2023-11-15 4:35 pm Unchanged | 2023-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 18.300% | 0 (Unchanged) | Filing History |
| 2023-01-05 4:31 pm Sale | 2023-01-03 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 19.700% | -12,467,432![]() (-95.65%) | Filing History |
| 2022-11-17 4:40 pm Sale | 2022-11-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 186,861 6.400% | -145,506![]() (-43.78%) | Filing History |
| 2022-02-10 4:02 pm Sale | 2021-12-31 | 13G | ANCHIANO THERAPEUTICS LTD ANCN | Gabriel Capital Management Ltd. | 3,087,040 1.400% | -5,781,506![]() (-65.19%) | Filing History |
| 2022-01-20 06:01 am Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 332,367 11.500% | 332,367![]() (New Position) | Filing History |
| 2021-04-15 5:28 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Access Industries Holdings LLC | 1,264,442 2.360% | 1,264,442![]() (New Position) | Filing History |
| 2021-03-26 4:06 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 13,034,955 24.300% | 13,034,955![]() (New Position) | Filing History |
| 2021-03-26 08:10 am Purchase | 2021-03-16 | 13G | Chemomab Therapeutics Ltd. CMMB | PETER THIEL | 5,657,815 10.600% | 5,657,815![]() (New Position) | Filing History |
| 2020-12-21 4:31 pm Unchanged | 2020-12-14 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 42.700% | 0 (Unchanged) | Filing History |
| 2020-12-17 5:36 pm Sale | 2020-12-17 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Palisade Medical Equity I LP | 0 0.000% | -1,848,200![]() (Position Closed) | Filing History |

